CAJ | 학술논문

直肠癌术后局部复发(LRRC)是直肠癌患者死亡的重要原因.虽然影像学技术、新辅助治疗和全直肠系膜切除手术已取得一定的进展,但直肠癌术后仍有高达10％的局部复发率.对于LRRC的患者,非手术治疗包括放疗、化疗只能延长约1年的生存时间.随着手术技术的不断提高,盆腔重建和手术并发症的处理不断完善,LRRC再次手术的治愈率也得到提高.以手术为主的综合治疗是LRRC的治疗关键,本文将对LRRC的手术治疗进展进行综述以飨同道.
직장암술후국부복발(LRRC)시직장암환자사망적중요원인.수연영상학기술、신보조치료화전직장계막절제수술이취득일정적진전,단직장암술후잉유고체10％적국부복발솔.대우LRRC적환자,비수술치료포괄방료、화료지능연장약1년적생존시간.수착수술기술적불단제고,분강중건화수술병발증적처리불단완선,LRRC재차수술적치유솔야득도제고.이수술위주적종합치료시LRRC적치료관건,본문장대LRRC적수술치료진전진행종술이향동도.
Local recurrent rectal cancer (LRRC) is located in the pelvis with or without distant metastasis.It is life-threatening for patients with rectal cancer.Despite the addition of imaging technology,preoperative neoadjuvant therapy and total mesorectal excision,loco-regional relapse still occurs with an incidence as high as 10％ in recent reports.Non-operative approaches to management such as radiotherapy and chemotherapy can only prolong survival time by 1 year.Improvements in surgical techniques,reconstruction methods and management of preoperative complications have helped increase the cure rate of patients with recurrent rectal cancer.Multimodality therapy based on surgery is the key of treating LRRC.This review article highlights the progress in surgical managements for local recurrent rectal cancer.